Source: ALL
Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs111618861
rs111618861 		0.700 GeneticVariation GWASCAT Genetic variants associated with antithyroid drug-induced agranulocytosis: a genome-wide association study in a European population. 27157822

2016
dbSNP: rs111703385
rs111703385 		A 0.700 GeneticVariation GWASCAT Clozapine-induced agranulocytosis is associated with rare HLA-DQB1 and HLA-B alleles. 25187353

2014
dbSNP: rs114431066
rs114431066 		0.700 GeneticVariation GWASCAT Sulfasalazine-Induced Agranulocytosis Is Associated With the Human Leukocyte Antigen Locus. 28762467

2018
dbSNP: rs116869525
rs116869525 		T 0.700 GeneticVariation GWASCAT Genetic determinants of antithyroid drug-induced agranulocytosis by human leukocyte antigen genotyping and genome-wide association study. 26151496

2015
dbSNP: rs117767021
rs117767021 		0.700 GeneticVariation GWASCAT Sulfasalazine-Induced Agranulocytosis Is Associated With the Human Leukocyte Antigen Locus. 28762467

2018
dbSNP: rs148071215
rs148071215 		A 0.700 GeneticVariation GWASCAT Clozapine-induced agranulocytosis is associated with rare HLA-DQB1 and HLA-B alleles. 25187353

2014
dbSNP: rs149020156
rs149020156 		0.700 GeneticVariation GWASCAT Sulfasalazine-Induced Agranulocytosis Is Associated With the Human Leukocyte Antigen Locus. 28762467

2018
dbSNP: rs16919354
rs16919354 		0.700 GeneticVariation GWASCAT Sulfasalazine-Induced Agranulocytosis Is Associated With the Human Leukocyte Antigen Locus. 28762467

2018
dbSNP: rs17193122
rs17193122 		A 0.700 GeneticVariation GWASCAT Genetic determinants of antithyroid drug-induced agranulocytosis by human leukocyte antigen genotyping and genome-wide association study. 26151496

2015
dbSNP: rs1811197
rs1811197 		0.700 GeneticVariation GWASCAT Genetic variants associated with antithyroid drug-induced agranulocytosis: a genome-wide association study in a European population. 27157822

2016
dbSNP: rs185386680
rs185386680 		0.700 GeneticVariation GWASCAT HLA-B*38:02:01 predicts carbimazole/methimazole-induced agranulocytosis. 26599303

2016
dbSNP: rs202233001
rs202233001 		0.700 GeneticVariation GWASCAT Sulfasalazine-Induced Agranulocytosis Is Associated With the Human Leukocyte Antigen Locus. 28762467

2018
dbSNP: rs74997117
rs74997117 		0.700 GeneticVariation GWASCAT Sulfasalazine-Induced Agranulocytosis Is Associated With the Human Leukocyte Antigen Locus. 28762467

2018
dbSNP: rs80208670
rs80208670 		C 0.700 GeneticVariation GWASCAT Genome-wide common and rare variant analysis provides novel insights into clozapine-associated neutropenia. 27400856

2017
dbSNP: rs9266634
rs9266634 		0.700 GeneticVariation GWASCAT Sulfasalazine-Induced Agranulocytosis Is Associated With the Human Leukocyte Antigen Locus. 28762467

2018
dbSNP: rs9372971
rs9372971 		0.700 GeneticVariation GWASCAT Sulfasalazine-Induced Agranulocytosis Is Associated With the Human Leukocyte Antigen Locus. 28762467

2018
dbSNP: rs184597564
rs184597564
ADGRL2
A 0.700 GeneticVariation GWASCAT Genome-wide common and rare variant analysis provides novel insights into clozapine-associated neutropenia. 27400856

2017
dbSNP: rs1800625
rs1800625
AGER ; PBX2
G 0.700 GeneticVariation GWASCAT Pharmacogenomic Study of Clozapine-Induced AgranulocytosisGranulocytopenia in a Japanese Population. 26876947

2016
dbSNP: rs622871
rs622871
C2 ; CYP21A2
0.700 GeneticVariation GWASCAT Sulfasalazine-Induced Agranulocytosis Is Associated With the Human Leukocyte Antigen Locus. 28762467

2018
dbSNP: rs143354638
rs143354638
CD8B2
0.700 GeneticVariation GWASCAT Sulfasalazine-Induced Agranulocytosis Is Associated With the Human Leukocyte Antigen Locus. 28762467

2018
dbSNP: rs12082628
rs12082628
CHRM3 ; LOC105373225
0.700 GeneticVariation GWASCAT Sulfasalazine-Induced Agranulocytosis Is Associated With the Human Leukocyte Antigen Locus. 28762467

2018
dbSNP: rs652888
rs652888
CYP21A2 ; EHMT2 ; EHMT2-AS1 ; LOC107986588
0.700 GeneticVariation GWASCAT Three SNPs were strongly associated with antithyroid drug-induced agranulocytosis: rs652888 (OR 4·73, 95% CI 3·00-7·44, p=1·92 × 10(-11)) and rs199564443 (17·42, 7·38-41·12, p=7·04 × 10(-11)), which were independent of HLA-B*27:05, and rs1071816 (5·27, 3·06-9·10, p=2·35 × 10(-9)) which was in moderate linkage disequilibrium with HLA-B*27:05. 27157822

2016
dbSNP: rs199564443
rs199564443
FOXF2 ; LOC105374880
0.700 GeneticVariation GWASCAT Three SNPs were strongly associated with antithyroid drug-induced agranulocytosis: rs652888 (OR 4·73, 95% CI 3·00-7·44, p=1·92 × 10(-11)) and rs199564443 (17·42, 7·38-41·12, p=7·04 × 10(-11)), which were independent of HLA-B*27:05, and rs1071816 (5·27, 3·06-9·10, p=2·35 × 10(-9)) which was in moderate linkage disequilibrium with HLA-B*27:05. 27157822

2016
dbSNP: rs76801208
rs76801208
GNAS
0.700 GeneticVariation GWASCAT Sulfasalazine-Induced Agranulocytosis Is Associated With the Human Leukocyte Antigen Locus. 28762467

2018
dbSNP: rs150938367
rs150938367
GSE1
0.700 GeneticVariation GWASCAT Sulfasalazine-Induced Agranulocytosis Is Associated With the Human Leukocyte Antigen Locus. 28762467

2018